Table: Kyorin Pharmaceutical -2023/24 group results

Kyorin Pharmaceutical

10/05/2024 07:00

May 10 (Reuters)- 
          Kyorin Pharmaceutical Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2024    Mar 31, 2023   Mar 31, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          119.53          113.27         123.40        56.90    
               (+5.5 pct)      (+7.3 pct)     (+3.2 pct)    (+3.6 pct) 
  Operating        6.01            5.12           6.50         1.00    
               (+17.4 pct)     (+2.3 pct)     (+8.1 pct)   (-12.6 pct) 
  Recurring        6.60            5.83           6.90         1.30    
               (+13.3 pct)     (+4.6 pct)     (+4.5 pct)    (-6.3 pct) 
  Net
  Net              5.32            4.72           5.00       900 mln   
               (+12.7 pct)     (+20.1 pct)    (-6.1 pct)   (-48.8 pct) 
  EPS           92.74 yen       82.44 yen      87.03 yen    15.67 yen  
  Ann Div       52.00 yen       52.00 yen      52.00 yen               
  -Q2 Div       20.00 yen       20.00 yen      20.00 yen               
  -Q4 Div       32.00 yen       32.00 yen      32.00 yen               
  
  NOTE - Kyorin Pharmaceutical Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T